OrthAlign, Inc. Adds Balance Feature to their Lantern(R) Platform, Including Indications for Primary and Revision Knee Arthroplasty

OrthAlign

PR98576

 

ALISO VIEJO, Calif., Nov. 1, 2022 /PRNewswire=KYODO JBN/ --

 

New feature offers soft-tissue balancing to aid in accurate component

positioning

 

With its recent addition of the Balance feature to the Lantern platform,

OrthAlign, Inc. is delivering an efficient, easy-to-use, cost-effective

instrument that aids surgeons in soft-tissue balancing during primary and

revision knee replacement procedures.

 

Photo -

https://mma.prnewswire.com/media/1934354/OrthAlign_Balancing_data_screen.jpg

 

The first soft-tissue feature to appear as part of the Lantern Knee

application, Balance works in conjunction with the company's Lantern handheld

device, a smart-phone sized instrument that allows for accurate positioning

during partial and total knee arthroplasty.

 

The initial release spanned over ten states, reaching from Hawaii, to

California, to Florida, and Connecticut, with surgeons using Lantern Balance in

both primary and revision knee procedures to provide accurate component

positioning and ligament balancing. The feature gives surgeons intra-operative

information of the patient's flexion and extension gaps, which is a game

changer for Lantern.

 

"With technology becoming the standard of care in total joint replacement,

delivering operationally and economically efficient technologies is key.

Lantern Balance is designed to provide personalized alignment without the need

for pre-operative imaging or capital equipment. Now, with Lantern, surgeons can

take advanced surgical technologies to any site of service with ease," says

Eric Timko, Chairman and CEO of OrthAlign.

 

According to Michael Ast, MD, Chief Medical Innovation Officer of the Hospital

for Special Surgery in New York, soft-tissue balancing is one of the most

critical steps for a successful knee replacement.

 

Currently, most surgeons balance the soft-tissue using manual qualitative

methods; Balance provides quantitative support to enhance accuracy.

 

"Determining a patient's balance has historically relied on a surgeon's ability

and skill, which presents difficulties as it relates to reproducibility and

standardization across surgeons. Modern technology, like the Lantern Balance

System, now allows surgeons to more precisely and repeatedly measure the

ligament tension of the knee to balance the knee in a manner that is both

individualized for that patient and reproduceable across surgeons and sites of

service," Ast says.

 

"It is pertinent now more than ever that patients receive a high level of care

from their surgeons using the most advanced technology available," says

OrthAligns CEO Timko, adding, "Lantern just got brighter with this new,

cutting-edge application."

 

OrthAlign, Inc., is a privately held U.S.-based medical device company that

provides orthopedic surgeons with advanced precision computer-assisted

technologies designed to deliver healthier and more pain-free lifestyles to

joint replacement patients.

Driven by the belief that everyone deserves exceptional healthcare, we are

committed to making empowering technologies accessible to all.

 

For more information regarding OrthAlign, please visit www.orthalign.com.

 

"ORTHALIGN(R), ORTHALIGN PLUS(R), LANTERN(R), KNEEALIGN(R), HIPALIGN(R) and

UNIALIGN(R)" are registered trademarks of OrthAlign, Inc.

 

 

SOURCE: OrthAlign

 

CONTACT: Nic Aldrich, OrthAlign, Inc., Tel: 949-525-9027, naldrich@orthalign.com

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中